Status:
COMPLETED
Developing Lung Cancer Screening in Hodgkin Lymphoma Survivors: a Qualitative Study
Lead Sponsor:
The Christie NHS Foundation Trust
Conditions:
Hodgkin Lymphoma
Eligibility:
All Genders
18-80 years
Brief Summary
To explore the topic of lung cancer screening following treatment for Hodgkin lymphoma from the perspective of survivors
Detailed Description
Explore survivors' attitudes towards lung cancer and lung cancer screening Explore survivors' understanding of cancer screening as a concept and the benefits of screening and early detection Explore s...
Eligibility Criteria
Inclusion
- Details held in the ADAPT database at The Christie NHS Foundation trust
- Responded to most recent ADAPT study questionnaire (April - August 2019)
- Aged 18-80
- Previously treated for Hodgkin lymphoma without evidence of relapse for at least 5 years
- Able to provide informed consent
- Treated with radiotherapy (with lung tissue in the radiotherapy field) and/or alkylating agent containing chemotherapy.
Exclusion
- Previous or current diagnosis of lung cancer
- Stated within 2019 health questionnaire that they did not wish to be contacted
- Have participated in lung cancer screening through the Manchester Lung Health Checks
Key Trial Info
Start Date :
February 11 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 13 2020
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT04396119
Start Date
February 11 2020
End Date
April 13 2020
Last Update
September 3 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Christie NHS Foundation Trust
Manchester, United Kingdom, M20 4BX